2021
Sheep as a Potential Model of Intradiscal Infection by the Bacterium Cutibacterium acnes
COSCIA, E.C., N.S. ABUTALEB, B. HOSTETTER, M.N. SELEEM, G.J. BREUR et. al.Základní údaje
Originální název
Sheep as a Potential Model of Intradiscal Infection by the Bacterium Cutibacterium acnes
Autoři
COSCIA, E.C., N.S. ABUTALEB, B. HOSTETTER, M.N. SELEEM, G.J. BREUR, R.R. MCCAIN, C.J. CRAIN, Ondřej SLABÝ (203 Česká republika, garant, domácí), M.N. CAPOOR, A. MCDOWELL, externista FAHAD AHMED (840 Spojené státy), V. VIJAYANPILLAI, S.K. NARAYANAN a M.F. COSCIA
Vydání
Polish Journal of Veterinary Sciences, Olsztyn, Polish Academy of Sciences Committee of Veterinary Sciences, University of Warmia and Mazury in Olsztyn, 2021, 2306-7381
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
40301 Veterinary science
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.518
Kód RIV
RIV/00216224:14740/21:00124251
Organizační jednotka
Středoevropský technologický institut
UT WoS
000634239500001
Klíčová slova anglicky
Cutibacterium acnes; sheep model; spinal intervertebral discs; percutaneous injections; bacterial discitis
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 18. 5. 2022 13:39, Mgr. Pavla Foltynová, Ph.D.
Anotace
V originále
The anaerobic bacterium Cutibacterium acnes has been increasingly linked to the development of degenerative disc disease (DDD), although causality is yet to be conclusively proven. To better study how this organism could contribute to the aetiology of DDD, improved animal models that are more reflective of human disc anatomy, biology and mechanical properties are required. Against this background, our proof-of concept study aimed to be the first demonstration that C. acnes could be safely administered percutaneously into sheep intervertebral discs (IVDs) for in vivo study. Following our protocol, two sheep were successfully injected with a strain of C. acnes (8.3 x 10(6) CFU/disc) previously recovered from a human degenerative disc. No adverse reactions were noted, and at one-month post inoculation all triplicate infected discs in our first animal grew C. acnes, albeit at a reduced load (5.12 x 10(4) to 6.67 x 10(4) CFU/disc). At six months, no growth was detected in discs from our second animal indicating bacterial clearance. This pilot study has demonstrated the feasibility of safe percutaneous injection of C. acnes into sheep IVDs under fluoroscopic guidance. The design of follow-up sheep studies to investigate the potential of C. acnes to drive pathological changes within infected discs should now be pursued.